Member Info for TruroTrader

Hi KingHomer, Siennaj isn't exactly friendly in the responses - almost dismissive and rude to boot. I'm tempted to ignore them in the future, there's nothing to gain by reading them - possibly even the green box!

Hi Siennaj, I think your a little pessimistic re Val. Our chances of success are well over 50% I reckon. If your that concerned you could ask JM for an update in Wednesday's Investor meeting?

The SP is a disappointment but look at the recent international performances of both primary and secondary stock markets - YGEN is not alone!

We doubled our revenue last year with Covid testing. The future SP will depend on how quickly we can replace that income.

We appear to have an unique NIPT 'Ranger' advantage into the USA. This is the worlds biggest healthcare market and we have over a hundred other products to follow that unique inroad. Scott Sargent will not let us miss a trick in the USA.

Our 'core' products have increasing sales - what's not to like?

Possibly not to big a problem as our income is increasingly from Europe and the States. It might reduce problem gambling but there again that's not a bad thing. Not to sure just what the take is with uncontrolled gambling but I know it can be destructive.

iloveshushi, You're making incorrect and possibly foolish sweeping statements. On the 24th of July 2020 I sold at 16.36p. All had been bought at single figures. I've since bought back, largely this year and the last, again in single figures. I am well in profit. As for 85% losing money in shares (never mind 99.99%!) This is plainly wrong as the vast majority of the UK working population are enrolled in pension schemes which have a large proportion of their funds in shares. My own personal Pension und has done very well thank you over the years as has my Company Pension scheme.

I wonder if you have any pension schemes - if so have a look. In addition have a look at the stellar performance of some of the Investment Trust market. Millions of UK holders have had great successes there. Lastly look at the Stocks and Shares ISA market. Again some real tax free money being made.

We don't know just how financially significant the Tipico launch is. It would appear to be another operator in an already licensed State so perhaps that is not a particularly big deal? An RNS has a cost to it and also certain regulatory parameters. Comparing Linkedin to RNS is difficult as they have different purposes.

No block sales are the problem. Processed stone appears to be selling, but not in amounts to make us any real money.

We are just hanging in there as we have been doing for the last few years. I'm not in 'terror' but it becomes increasingly important that the compo comes through in a year or two. It actually was ever thus since the Malesheva quarry was closed. We still have 3 months to relist and I think that with CG's ability to keep on swinging and the recent new NED
there is a plan which, cunning or not!, has certain merits. There is a world wide requirement for companies such as Eco-Building. Modular construction has to be a way forward.

Quite a little flurry of buys this morning. Contract coming?

Indeed PYC is well funded with a unique in demand product and a competent BoD with an effective business model that will produce breakeven/profits anytime soon. As for SH getting shafted, well at least it should be cash that they can afford to lose - it's happened to me on numerous occasions! But most of the employees, many who may have done their best and worked above and beyond to avert the catastrophe, lose their livelihoods and sometimes with no warning or compensation. That's a real cost.

Err - OK Kidling - you may have a point, sort of!! Yes indeed a mega company - this just demonstrates how our product is in fact attracting real attention from all and sundry. In my book PYC really has a USP. Crucially, software is cheap to reproduce and so our cost base will not drag down revenue. Happy Days are just around the corner!!

Hi Kidlington, This was announced a month or so after the interims RNS and part of the stated pipeline but I don't think Servier is that large? Possibly that one still to come?

Hi ooofffttt, Didn't mean to insult you but I genuinely hadn't realised that you were referring to the interim statement. That was only some 3.5 months ago and the Servier contract was already announced. My take on that was that although they were described as discussions that were advanced experience shows that time is still needed - particularly with the larger companies we are now dealing with.

Once the arbitration actually starts then it's probably a matter of days or a week or two because the outcome of that is legally binding - there is no appeal process. But it could take a couple of years or so to get it started!

PS If we win lets hope they've got some money!!!

1) You called what was announced as contracts a pipeline. You can't turn existing contracts into contract/sales as they're already a fact!

2) This is a personal decision and I would be surprised at any comment.

However if you truly want a response from JM then this is not the place to pose those questions. As regards the low SP, I have 6 companies on AIM 1 of which is suspended and the remaining 5 are all in the same boat as PYC in that they are looking to breakeven/break into profit. All are at their lowest SP for 12 months or over - it's just the way it is. Markets are down.

Scott Sargent is not on the BoD. So ergo he's ' Upper Management'. You are delusional if you want to oust him!!!

Good June so far. Three new agreements this month - can only add to next years revenue. As already mentioned we have a low cost base that is already covered and profits are assured. Roll on the half year update - got to be very good!

Indeedy Yes, 12 months ago our SP was double at 6/7P. PYC is in a far better place now. Small trades have been a feature and previous posters, over some years, have commented on low 'floating shares' situation with share shortage skewing things. Not that I understand this shortage?

However the sheer number of both small and large successful companies that we are linked with is proof of our Virtual Tumor offering and the subsequent new business collaborations. Never mind the SP - this company is about to strongly increase revenue with little extra cost to the bottom line. Oh happy days!!

Just a little but harsh! PYC is a very tight knit operation. Last years accounts show only 7 employees. I think we are now at 9. Because of this the BoD is very much hands on and alive to PYC's real situation. The latest NED was in fact an advisor anyway. Because we are extremely specialised we have a very targeted approach. This can be a danger of course but Cancer research is now getting massive attention and PYC is ideally poised to benefit. Wait for the June accounts and perhaps re-think your opinion?

John, It may well be that the forced closing of the Malesheva quarry is a contributory factor into making no profits? That point would seem to have some merit plus of course detrimental publicity. The people who funded the action plus of course Dentons seem to have a more positive attitude - I just hope their right!

blueril, I was thinking more of trading updates than the relisting progress. I. E. there was a trading update re processed stone last May and June is our year end. I would like to see updates on those points plus of course any news on block sales. As I've posted before I'm fairly relaxed re the relisting and any compo would give the new business a massive boost.

Last June year end was preceded by an April update that sugared the pill a little. Although sales were not as expected because of Covid drag other positive measures were announced. This year will be different as my guess is that record revenues will get us close to breakeven if not in profits. However my interest will be on the progress of the various business streams. If these are positive then I feel that we may well see an SP increase to reflect this and 6/7p may well be achievable because although our basic running costs will have risen because of head count increases our other costs are pretty stable. Hopefully get an update in some 6 weeks or so?

Got a good feeling about this company - it's in the right oncology sector at a time when personalised medical drugs are being researched in a wide and growing area. Onwards and upwards folks!

Yes, I had one before that delisted and then disappeared into the wilderness. I think our saving grace may be the appointment of Sir Mark Grant as a NED. He seems pretty high powered and with his experience of arbitration he must be a plus. Well I hope so!!